BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21317927)

  • 1. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.
    Schramedei K; Mörbt N; Pfeifer G; Läuter J; Rosolowski M; Tomm JM; von Bergen M; Horn F; Brocke-Heidrich K
    Oncogene; 2011 Jun; 30(26):2975-85. PubMed ID: 21317927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-139-5p inhibits proliferation and promoted apoptosis of human airway smooth muscle cells by downregulating the Brg1 gene.
    Zhang H; Sun Z; Yu L; Sun J
    Respir Physiol Neurobiol; 2017 Dec; 246():9-16. PubMed ID: 28711603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression inactivation of SMARCA4 by microRNAs in lung tumors.
    Coira IF; Rufino-Palomares EE; Romero OA; Peinado P; Metheetrairut C; Boyero-Corral L; Carretero J; Farez-Vidal E; Cuadros M; Reyes-Zurita FJ; Lupiáñez JA; Sánchez-Cespedes M; Slack FJ; Medina PP
    Hum Mol Genet; 2015 Mar; 24(5):1400-9. PubMed ID: 25355421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP32A regulates histone H3 acetylation and promotes leukemogenesis.
    Yang X; Lu B; Sun X; Han C; Fu C; Xu K; Wang M; Li D; Chen Z; Opal P; Wen Q; Crispino JD; Wang QF; Huang Z
    Leukemia; 2018 Jul; 32(7):1587-1597. PubMed ID: 29467488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
    Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
    Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gga-miR-181a modulates ANP32A expression and inhibits MDCC-MSB-1 cell.
    Li X; Zhao C; Han B; Qu L; Liu C; Yang N; Lian L
    In Vitro Cell Dev Biol Anim; 2021 Mar; 57(3):272-279. PubMed ID: 33686586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.
    Noguchi S; Mori T; Otsuka Y; Yamada N; Yasui Y; Iwasaki J; Kumazaki M; Maruo K; Akao Y
    J Biol Chem; 2012 Apr; 287(15):11769-77. PubMed ID: 22354972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microRNA-199a-5p ameliorates oxygen-glucose deprivation/reoxygenation-induced apoptosis and oxidative stress in HT22 neurons by targeting Brg1 to activate Nrf2/HO-1 signalling.
    Li F; Liang J; Tong H; Zhu S; Tang D
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1020-1029. PubMed ID: 31990992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
    Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
    Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines.
    Cuadros M; Sánchez-Martín V; Herrera A; Baliñas C; Martín-Padrón J; Boyero L; Peinado P; Medina PP
    Clin Transl Oncol; 2017 Aug; 19(8):1010-1017. PubMed ID: 28251496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis suppressor microRNA-335 targets the formin family of actin nucleators.
    Lynch J; Meehan MH; Crean J; Copeland J; Stallings RL; Bray IM
    PLoS One; 2013; 8(11):e78428. PubMed ID: 24223803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of microRNA-144-3p attenuates oxygen-glucose deprivation/reoxygenation-induced neuronal injury by promoting Brg1/Nrf2/ARE signaling.
    Li Y; Zhao Y; Cheng M; Qiao Y; Wang Y; Xiong W; Yue W
    J Biochem Mol Toxicol; 2018 Apr; 32(4):e22044. PubMed ID: 29457851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.
    Tagne JB; Mohtar OR; Campbell JD; Lakshminarayanan M; Huang J; Hinds AC; Lu J; Ramirez MI
    Respir Res; 2015 Feb; 16(1):22. PubMed ID: 25763778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
    Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
    J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.
    Chen Y; Liu W; Chao T; Zhang Y; Yan X; Gong Y; Qiang B; Yuan J; Sun M; Peng X
    Cancer Lett; 2008 Dec; 272(2):197-205. PubMed ID: 19013014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
    He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
    Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
    Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.